TransUnion price target raised to $105 from $104 at BMO Capital

Investing.com - BMO Capital has raised its price target on TransUnion (NYSE:TRU) to $105 from $104 while maintaining an Outperform rating on the credit reporting company’s stock. According to InvestingPro data, TransUnion currently trades at $83.48 with a market capitalization of $16.2 billion, showing strong financial health metrics with a current ratio of 2.02.

The price target adjustment follows TransUnion’s latest quarterly earnings report, which BMO described as a "beat and raise" performance as lending conditions remained stable across most markets, with only a slight decline noted in India. InvestingPro data reveals impressive gross profit margins of 59.25% and solid revenue growth of 9.34% over the last twelve months.

TransUnion management was active in share repurchases during the quarter and increased its repurchase authorization by $500 million, demonstrating confidence in the company’s financial position.

BMO made minor adjustments to its revenue estimates following the stronger-than-expected performance, though the firm remains "a bit more conservative on margin expansion" despite potential benefits from the company’s OneTru cost initiative.

TransUnion management also indicated plans for an upcoming Investor Day to be held in early 2026, which will likely provide more details on the company’s long-term strategy and financial outlook.

In other recent news, TransUnion reported its third-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of $1.10, compared to the forecast of $1.04. The company also exceeded revenue projections, reporting $1.17 billion against the anticipated $1.13 billion. These results mark a 5.77% earnings surprise and a 3.54% revenue surprise. The announcement of these financial results came alongside a noticeable premarket stock price increase. Additionally, while the earnings call focused on the financial outcomes, it also highlighted the company’s ongoing operational strategies. Analysts have taken note of these developments, with several firms maintaining their current ratings on the stock. There have been no recent upgrades or downgrades from major analyst firms. These recent developments provide investors with a detailed look at TransUnion’s financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.